Variant report
Variant | nsv1027674 |
---|---|
Chromosome Location | chr9:10016077-10045136 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:53)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr9:10026580-10026730 | RPTEC | kidney: | n/a | chr9:10026618-10026634 chr9:10026619-10026640 |
2 | CTCF | chr9:10026619-10026648 | GM12878 | blood: | n/a | chr9:10026619-10026640 |
3 | CTCF | chr9:10026520-10026670 | GM12872 | blood: | n/a | chr9:10026618-10026634 chr9:10026619-10026640 |
4 | CTCF | chr9:10026593-10026664 | Gliobla | brain: | n/a | chr9:10026618-10026634 chr9:10026619-10026640 |
5 | CTCF | chr9:10026629-10026674 | GM10248 | blood: | n/a | n/a |
6 | CTCF | chr9:10026500-10026650 | GM12869 | blood: | n/a | chr9:10026618-10026634 chr9:10026619-10026640 |
7 | CTCF | chr9:10022144-10022258 | GM20000 | blood: | n/a | n/a |
8 | CTCF | chr9:10026570-10026680 | HepG2 | liver: | n/a | chr9:10026618-10026634 chr9:10026619-10026640 |
9 | CTCF | chr9:10026484-10026732 | GM12878 | blood: | n/a | chr9:10026618-10026634 chr9:10026619-10026640 |
10 | CTCF | chr9:10026640-10026790 | HMEC | breast: | n/a | n/a |
11 | CTCF | chr9:10026500-10026650 | RPTEC | kidney: | n/a | chr9:10026618-10026634 chr9:10026619-10026640 |
12 | CTCF | chr9:10022429-10022533 | GM10248 | blood: | n/a | n/a |
13 | CTCF | chr9:10026540-10026690 | HL-60 | blood: | n/a | chr9:10026618-10026634 chr9:10026619-10026640 |
14 | CTCF | chr9:10026540-10026690 | GM12872 | blood: | n/a | chr9:10026618-10026634 chr9:10026619-10026640 |
15 | CTCF | chr9:10026520-10026670 | WERI-Rb-1 | eye: | n/a | chr9:10026618-10026634 chr9:10026619-10026640 |
16 | CTCF | chr9:10026578-10026668 | MCF-7 | breast: | n/a | chr9:10026618-10026634 chr9:10026619-10026640 |
17 | CTCF | chr9:10026544-10026711 | Medullo | brain: | n/a | chr9:10026618-10026634 chr9:10026619-10026640 |
18 | CTCF | chr9:10026548-10026679 | HUVEC | blood vessel: | n/a | chr9:10026618-10026634 chr9:10026619-10026640 |
19 | CTCF | chr9:10026540-10026690 | HRE | kidney: | n/a | chr9:10026618-10026634 chr9:10026619-10026640 |
20 | CTCF | chr9:10026665-10026669 | Gliobla | brain: | n/a | n/a |
21 | E2F4 | chr9:10034915-10034979 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | FOS | chr9:10032317-10032463 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | FOS | chr9:10032288-10032456 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | FOXA1 | chr9:10026464-10026736 | HepG2 | liver: | n/a | n/a |
25 | FOXA2 | chr9:10026542-10026741 | HepG2 | liver: | n/a | n/a |
26 | MAFF | chr9:10042173-10042587 | HepG2 | liver: | n/a | chr9:10042281-10042299 |
27 | MAFK | chr9:10042163-10042590 | HepG2 | liver: | n/a | chr9:10042491-10042506 chr9:10042496-10042507 chr9:10042495-10042506 chr9:10042495-10042506 chr9:10042496-10042507 chr9:10042277-10042297 |
28 | MAFK | chr9:10042169-10042592 | HepG2 | liver: | n/a | chr9:10042491-10042506 chr9:10042496-10042507 chr9:10042495-10042506 chr9:10042495-10042506 chr9:10042496-10042507 chr9:10042277-10042297 |
29 | MYC | chr9:10026707-10026965 | NB4 | blood: | n/a | n/a |
30 | POLR2A | chr9:10024203-10024479 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr9:10027118-10027254 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr9:10036077-10036570 | H1-neurons | neurons: | n/a | n/a |
33 | POLR2A | chr9:10021840-10021979 | GM12878 | blood: | n/a | n/a |
34 | POLR2A | chr9:10016977-10016987 | GM12878 | blood: | n/a | n/a |
35 | POLR2A | chr9:10036155-10036305 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | POLR2A | chr9:10034954-10035075 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | POLR2A | chr9:10017527-10017712 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | POLR2A | chr9:10023129-10023329 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | POLR2A | chr9:10027509-10027773 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | POLR2A | chr9:10041778-10041927 | MCF10A-Er-Src | breast: | n/a | n/a |
41 | POLR2A | chr9:10024338-10024367 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | POLR2A | chr9:10036142-10036532 | H1-neurons | neurons: | n/a | n/a |
43 | RAD21 | chr9:10026487-10026797 | H1-hESC | embryonic stem cell: | n/a | chr9:10026618-10026637 |
44 | RAD21 | chr9:10026503-10026762 | H1-hESC | embryonic stem cell: | n/a | chr9:10026618-10026637 |
45 | RAD21 | chr9:10026514-10026728 | H1-hESC | embryonic stem cell: | n/a | chr9:10026618-10026637 |
46 | SMC3 | chr9:10026561-10026661 | HepG2 | liver: | n/a | n/a |
47 | STAT3 | chr9:10032198-10032399 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | STAT3 | chr9:10032810-10033007 | MCF10A-Er-Src | breast: | n/a | n/a |
49 | STAT3 | chr9:10032255-10032455 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | STAT3 | chr9:10040791-10041056 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
PTPRD | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs189303470 | chr9:10022629-10022630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs555265156 | chr9:10022658-10022659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs71497169 | chr9:10022666-10022667 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs533792661 | chr9:10022698-10022699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148814146 | chr9:10022701-10022702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs192526818 | chr9:10022742-10022743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560044586 | chr9:10022802-10022803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184458659 | chr9:10023011-10023012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189322810 | chr9:10023012-10023013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576160980 | chr9:10023026-10023027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574953555 | chr9:10023110-10023111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs181230904 | chr9:10023120-10023121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551918118 | chr9:10023149-10023150 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs555386675 | chr9:10023158-10023159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs565361486 | chr9:10023171-10023172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs572077821 | chr9:10023172-10023173 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs541052958 | chr9:10023175-10023176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186473277 | chr9:10023202-10023203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577764324 | chr9:10023227-10023228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528852513 | chr9:10023244-10023245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563867670 | chr9:10023254-10023255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs16930832 | chr9:10023288-10023289 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs188624255 | chr9:10023328-10023329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs142514278 | chr9:10023370-10023371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs527261789 | chr9:10023378-10023379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs531164035 | chr9:10023397-10023398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550243931 | chr9:10023405-10023406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181428097 | chr9:10023412-10023413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs79454841 | chr9:10023421-10023422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs115606703 | chr9:10023426-10023427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs10809012 | chr9:10023441-10023442 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs569795967 | chr9:10023452-10023453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs535309803 | chr9:10023453-10023454 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs555611877 | chr9:10023464-10023465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs10809013 | chr9:10023484-10023485 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs534695785 | chr9:10023492-10023493 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs546191090 | chr9:10023511-10023512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557685948 | chr9:10023516-10023517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs572479494 | chr9:10023526-10023527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577626929 | chr9:10023528-10023529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs185911399 | chr9:10023546-10023547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs540773928 | chr9:10023548-10023549 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs190719665 | chr9:10023552-10023553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs77686479 | chr9:10023571-10023572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs184097330 | chr9:10023577-10023578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559192039 | chr9:10023593-10023594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs542887946 | chr9:10023616-10023617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs377726752 | chr9:10023621-10023622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs199708493 | chr9:10023624-10023625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs71485309 | chr9:10023632-10023633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
abnormal development | 18461090 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 21764851 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Gastric cancer | 16891809 | CNVD |
Mental retardation | 17847001 | CNVD |
Cutaneous squamous cell carcinomas | 17420988 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Lung adenocarcinoma | 17982442 | CNVD |
Breast cancer | 21611746 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:10022600-10024400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr9:10025600-10027400 | Enhancers | Dnd41 | blood |
3 | chr9:10025800-10027600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
4 | chr9:10026000-10026400 | Enhancers | Brain Anterior Caudate | brain |
5 | chr9:10026200-10027000 | Enhancers | Primary hematopoietic stem cells | blood |
6 | chr9:10026200-10027000 | Enhancers | Brain Cingulate Gyrus | brain |
7 | chr9:10026200-10027000 | Enhancers | Brain Substantia Nigra | brain |
8 | chr9:10026200-10027200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr9:10026400-10027000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
10 | chr9:10026600-10027200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr9:10028000-10030000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr9:10035600-10040000 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
13 | chr9:10040000-10040400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
14 | chr9:10040000-10040600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr9:10040000-10041000 | Enhancers | Fetal Heart | heart |
16 | chr9:10040400-10040600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
17 | chr9:10040400-10042200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
18 | chr9:10040600-10041200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr9:10040600-10041800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
20 | chr9:10040600-10046000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr9:10041000-10041600 | Weak transcription | Fetal Heart | heart |
22 | chr9:10041600-10042000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
23 | chr9:10041600-10042600 | Enhancers | Fetal Heart | heart |
24 | chr9:10041800-10042400 | Enhancers | Rectal Smooth Muscle | rectum |
25 | chr9:10041800-10042600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
26 | chr9:10041800-10042600 | Enhancers | Fetal Brain Female | brain |
27 | chr9:10042200-10042400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
28 | chr9:10042600-10048000 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |